Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by The Ken. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Ken or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Bansal chased vision. Nagori chased output. Public markets seem to prefer butter chicken over burpees

11:36
 
Share
 

Manage episode 498329966 series 3423246
Content provided by The Ken. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Ken or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Ankit Nagori and Mukesh Bansal may have started the fitness unicorn Cult.Fit together, but their journeys since then are a study in contrasts.

On one hand is Cult.Fit. It's been a little over a year since Mukesh Bansal stepped down as Cult’s CEO. When The Ken reached out to him asking why, he clarified that he still remains involved. But involvement, of course, is a spectrum – sometimes it means steering the company to an IPO.

The catch is that while Cult.fit wants to go public next year, there is no DRHP yet. There is also no FY25 data on the Ministry of Corporate Affairs website.

Then you have Nagori’s big bet – Cure.Foods. Under Nagori’s leadership, Curefoods went from 2 crore in revenue in FY21 to 775 crore in FY25. That’s according to its draft IPO documents filed in June.

Yup, Curefoods is also looking to go public. But unlike Cult, Nagori has a DRHP, a valuation, and a business that sells things people eat. While Eat.fit was all about quinoa and millets, Curefoods evetnually became about what sells. After all, the focus was to scale.

Tune in.

Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.

  continue reading

570 episodes

Artwork
iconShare
 
Manage episode 498329966 series 3423246
Content provided by The Ken. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Ken or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Ankit Nagori and Mukesh Bansal may have started the fitness unicorn Cult.Fit together, but their journeys since then are a study in contrasts.

On one hand is Cult.Fit. It's been a little over a year since Mukesh Bansal stepped down as Cult’s CEO. When The Ken reached out to him asking why, he clarified that he still remains involved. But involvement, of course, is a spectrum – sometimes it means steering the company to an IPO.

The catch is that while Cult.fit wants to go public next year, there is no DRHP yet. There is also no FY25 data on the Ministry of Corporate Affairs website.

Then you have Nagori’s big bet – Cure.Foods. Under Nagori’s leadership, Curefoods went from 2 crore in revenue in FY21 to 775 crore in FY25. That’s according to its draft IPO documents filed in June.

Yup, Curefoods is also looking to go public. But unlike Cult, Nagori has a DRHP, a valuation, and a business that sells things people eat. While Eat.fit was all about quinoa and millets, Curefoods evetnually became about what sells. After all, the focus was to scale.

Tune in.

Daybreak is produced from the newsroom of The Ken, India’s first subscriber-only business news platform. Subscribe for more exclusive, deeply-reported, and analytical business stories.

  continue reading

570 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play